T. Rowe Price Investment Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88M | Buy |
1,527,827
+112,424
| +8% | +$6.48M | 0.06% | 298 |
|
|
2025
Q1 | $82.5M | Buy |
1,415,403
+429,461
| +44% | +$25M | 0.05% | 313 |
|
|
2024
Q4 | $79.4M | Sell |
985,942
-45,785
| -4% | -$3.69M | 0.05% | 329 |
|
|
2024
Q3 | $82.7M | Sell |
1,031,727
-715,362
| -41% | -$57.3M | 0.05% | 332 |
|
|
2024
Q2 | $107M | Sell |
1,747,089
-1,192,830
| -41% | -$72.9M | 0.07% | 274 |
|
|
2024
Q1 | $145M | Sell |
2,939,919
-755,108
| -20% | -$37.3M | 0.09% | 232 |
|
|
2023
Q4 | $155M | Buy |
3,695,027
+44,928
| +1% | +$1.88M | 0.1% | 216 |
|
|
2023
Q3 | $120M | Buy |
3,650,099
+622,432
| +21% | +$20.4M | 0.08% | 239 |
|
|
2023
Q2 | $107M | Buy |
3,027,667
+302,378
| +11% | +$10.7M | 0.07% | 261 |
|
|
2023
Q1 | $77.4M | Buy |
2,725,289
+27,404
| +1% | +$778K | 0.06% | 300 |
|
|
2022
Q4 | $112M | Buy |
2,697,885
+124,102
| +5% | +$5.16M | 0.09% | 237 |
|
|
2022
Q3 | $107M | Buy |
+2,573,783
| New | +$107M | 0.09% | 230 |
|